Navigation Links
Elite Team of Cyclists with Type 1 Diabetes Powers Forward in 2008 Sponsored by Rapid-Acting Insulin Apidra(R)
Date:4/2/2008

- Inspirational Team of Athletes

- Team Type 1 - Spreads Messages of Hope to Others with Diabetes and Steers Toward Its

Ultimate Goal of Tour de France Competition

BRIDGEWATER, N.J., April 2, 2008 /PRNewswire-FirstCall/ -- Sanofi-aventis announced today its rapid-acting insulin Apidra(R) (insulin glulisine [rDNA origin] injection) will now become the primary sponsor of Team Type 1, a team of amateur and professional cyclists living with type 1 diabetes.

"Team Type 1 began as two friends challenging one another to take control of our diabetes and to become the best cyclists we possibly could. Today, we've grown into a diverse team of athletes from around the world, who have proven that not even diabetes can prevent us from accomplishing our dreams," said Phil Southerland, co-founder and president of Team Type 1. "We appreciate the ongoing support of sanofi-aventis in helping us bring this vision to other people with diabetes and move us even closer to our ultimate goal -- competing in the Tour de France."

In 2007, the team of ten cyclists, all with type 1 diabetes, won the 3,052 mile-long, cross-country Race Across America (RAAM) in a record 5 days, 15 hours and 43 minutes. With this increased level of support from sanofi-aventis, Team Type 1 will expand its roster in 2008 and field two teams: an amateur development level team for the 2008 RAAM comprised of 11 riders, all of whom have type 1 diabetes, and a professional level racing team featuring a mixed roster of 15 cyclists four of whom have diabetes. All members of Team Type 1 with diabetes use Apidra(R) in an insulin infusion pump to help control their high blood sugar.

"I began using Apidra(R) because my doctor recommended it as a fast and effective way to keep my blood sugars under control," continued Southerland. "Since starting Apidra(R), I have noticed how quickly it helps get my blood sugar down which
'/>"/>

SOURCE sanofi-aventis
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine technology :

1. Abbott Initiates Clinical Study to Evaluate Use of RX Herculink(R) Elite(TM) Renal Stent System for the Treatment of Renal Artery Stenosis
2. New Data Showed ACTOS(R) (pioglitazone HCl) Prevented Progression of Atherosclerotic Plaque Volume in Patients With Type 2 Diabetes
3. Synvista Therapeutics Presents New Preclinical Data Demonstrating the Value of Haptoglobin Genotype Testing In Diabetes at ACC Scientific Sessions
4. New York-Presbyterian/Weill Cornell is First New York Medical Center to Offer Tantalus Clinical Trial to Diabetes Patients
5. Reduced Lung Capacity Accelerates With Diabetes
6. Revised: Challenging the Norm May Lead to New Therapy for Type 2 Diabetes
7. Challenging the Norm May Lead to New Therapy for Type 2 Diabetes
8. Phosphagenics Initiates its Phase 2 Clinical Trial in Type 1 Diabetes
9. Diamyd(R) Diabetes Vaccine Receives Approval to Start Phase III Trials in Europe
10. UMDNJ-University Hospital in Newark to Tailor Diabetes Interventions for Low-Income and Minority Groups With Grant From the International Diabetes Federation
11. InteKrin Therapeutics Announces Initiation of Phase 2b Study in Type 2 Diabetes with INT131
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/20/2013)... Calif. , May 20, 2013 /PRNewswire-iReach/ -- ... of the first study demonstrating detection of pathogenic ... Yersinia pestis and Bacillus anthracis ... and Prevention,s list of potential bio-threats. This seminal ... and Technology Laboratory, Salisbury ...
(Date:5/20/2013)...  TRACE International today released its Global Enforcement ... against individuals and government or business entities for bribery ... 2012 is the third in an annual series ... "Although the number of outbound enforcement actions fell ... priority," said Alexandra Wrage , TRACE ...
(Date:5/20/2013)... EL SEGUNDO, Calif. , May 20, 2013 /PRNewswire/ ... helped perfect for use both in space and on ... of Fame. The technology assures high ... by compact and low-power ultrasound units, like those used ... ultrasound is already the diagnostic imaging solution of choice ...
Breaking Medicine Technology:Specific Technologies Detects and Identifies Potential Bioterrorism Pathogenic Bacteria 2TRACE Releases 2012 Global Enforcement Report 2TRACE Releases 2012 Global Enforcement Report 3Wyle Aided System Gets Named to Space Technology Hall of Fame 2Wyle Aided System Gets Named to Space Technology Hall of Fame 3
... Pharmaceuticals, Inc. (Nasdaq: MAPP ) today reported ... effects on pulmonary artery pressure of LEVADEX™, dihydroergotamine mesylate ... there was no statistically significant difference between the LEVADEX ... artery pressure over two hours after administration. LEVADEX is ...
... Isis Pharmaceuticals, Inc. (Nasdaq: ISIS ), the leader ... company overview at Stifel Nicolaus, 2010 Healthcare Conference on Thursday, ... Seasons Hotel in Boston, MA. A live audio ... & Media" section of the Company,s Web site, www.isispharm.com ...
Cached Medicine Technology:MAP Pharmaceuticals Reports No Difference in Pulmonary Artery Pressure Between LEVADEX™ and Placebo in Pharmacodynamics Trial 2MAP Pharmaceuticals Reports No Difference in Pulmonary Artery Pressure Between LEVADEX™ and Placebo in Pharmacodynamics Trial 3MAP Pharmaceuticals Reports No Difference in Pulmonary Artery Pressure Between LEVADEX™ and Placebo in Pharmacodynamics Trial 4
(Date:5/20/2013)... 2013 For the third consecutive ... of Frederick Award in the Professional Standards Review ... , The USCA "Best of Local Business" Award ... Each year, the USCA identifies companies that they ... local community and business category. These are local ...
(Date:5/20/2013)... The new healthcare bill proposes to ... all Americans. However, not all the conditions were to ... might take up to 2014 to show anything. ... states are currently moving forward to implement the health ... Iowa, Michigan, New Hampshire, and West Virginia. HHS will ...
(Date:5/20/2013)... Daily Gossip, online magazine about lifestyle, health and sports ... that can help them overcome one of the most spread ... Natural Vitiligo Treatment System has created a buzz on ... received from the persons who have tried it. Its principles ... interviewed some of the people who tried it and managed ...
(Date:5/20/2013)... People are so busy these days, running ... through the roof and are contributing to a number of ... mean the difference between life and death. Speakers at the ... May will share valuable, practical tools people can use to ... around them for social good. , Organised by V ...
(Date:5/20/2013)... (PRWEB) May 20, 2013 ... Foundation will be holding a ... Lansing on June 10th. , ... 10th, 6:30 p.m. – 8 ... (Across from Sparrow Hospital),                  ...
Breaking Medicine News(10 mins):Health News:A2LA Receives 2013 Best of Frederick Award 2Health News:Review of Health Bill Impact in 2014 2Health News:Review of Health Bill Impact in 2014 3Health News:New Natural Vitiligo Treatment System That Helps People Treat Vitiligo Permanently Revealed by Daily Gossip Magazine 2Health News:Chill Out and Change the World, Say Mind Experts at V Star Bliss Event in Sydney 2
... ... system that automatically matches the right clients with the right lenders making the whole ... conversions for retailers. , ... Orlando, FL (PRWEB) June 17, 2009 -- The world of Equipment Leasing/Financing is ...
... ORANGE COUNTY, Calif., June 17 Applied Medical, a ... in the Premier healthcare alliance ,s ... in healthcare while highlighting healthcare industry suppliers committed to ... Innovation Celebration highlights innovative solutions that bring a positive ...
... rescue manager won contest to clone beloved pet Trakr, hero of ... Can you clone a hero? Retired ... dog and 9-11 hero, Trakr, will receive five answers to that ... biotech company that is offering the first commercial dog cloning service ...
... Focus on promoting ... ... signed a Memorandum of Understanding (MOU) to promote healthcare travel in the Pacific Asia region. ... and drive more integration between the travel and healthcare industries., , , , ,Under the ...
... Dr. Bryan Selkin, the ... new state of the art location at 5044 Tennyson in Plano. Dr. Bryan Selkin will ... ... Selkin, the Chief Dermatologist of the Dermatology Center of Plano will be relocating his practice to ...
... Withdraws Two Cold Remedy Nasal Products Citing Commitment to Consumer ... Matrixx Initiatives, Inc. (Nasdaq: MTXX ) has ... U.S. Food and Drug Administration about two of its 19 ... Zicam Cold Remedy Swabs. The warning letter cited consumer reports ...
Cached Medicine News:Health News:The Equipment Leasing/Financing World Now Has its First Exclusive Online Referral Service 2Health News:The Equipment Leasing/Financing World Now Has its First Exclusive Online Referral Service 3Health News:Applied Medical Selected by the Premier Healthcare Alliance to Highlight Commitment to Healthcare Quality Improvement, Innovation 2Health News:Applied Medical Selected by the Premier Healthcare Alliance to Highlight Commitment to Healthcare Quality Improvement, Innovation 3Health News:BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles 2Health News:BioArts International Clones 9-11 Hero Dog - Owner to Receive Five Cloned Puppies June 17 in Los Angeles 3Health News:The International Medical Travel Association (IMTA) and Pacific Asia Travel Association (PATA) sign MOU to Promote Healthcare Travel 2Health News:The International Medical Travel Association (IMTA) and Pacific Asia Travel Association (PATA) sign MOU to Promote Healthcare Travel 3Health News:New State of the Art Dermatology Center in Plano TX 2Health News:Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel 2Health News:Matrixx Initiatives Voluntarily Withdraws Zicam Cold Remedy Swabs, Zicam Cold Remedy Nasal Gel 3
Inquire...
Using proven 1064 nm technology for the treatment of deeper lesions, the Lumenis One Multi-Spot Nd:YAG module provides versatility allowing targeted treatment of leg veins, vascular lesions, facial w...
... provides an ideal treatment for ... such as the great and ... wavelength targets water in the ... means a much more comfortable ...
...
Medicine Products: